Literature DB >> 22119708

In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs).

Emanuela Corsini1, Enrico Sangiovanni, Anna Avogadro, Valentina Galbiati, Barbara Viviani, Marina Marinovich, Corrado L Galli, Mario Dell'Agli, Dori R Germolec.   

Abstract

We have previously shown that PFOA and PFOS directly suppress cytokine secretion in immune cells, with different mechanisms of action. In particular, we have demonstrated a role for PPAR-α in PFOA-induced immunotoxicity, and that PFOS has an inhibitory effect on LPS-induced I-κB degradation. These studies investigate the immunomodulatory effects of four other PFCs, namely PFBS, PFOSA, PFDA, and fluorotelomer using in vitro assays. The release of the pro-inflammatory cytokines IL-6 and TNF-α was evaluated in lipolysaccharide (LPS)-stimulated human peripheral blood leukocytes (hPBL) and in the human promyelocytic cell line THP-1, while the release of IL-10 and IFN-γ was evaluated in phytohemagglutinin (PHA)-stimulated hPBL. All PFCs suppressed LPS-induced TNF-α production in hPBL and THP-1 cells, while IL-6 production was suppressed by PFOSA, PFOS, PFDA and fluorotelomer. PFBS, PFOSA, PFOS, PFDA and fluorotelomer inhibited PHA-induced IL-10 release, while IFN-γ secretion was affected by PFOSA, PFOS, PFDA and fluorotelomer. Leukocytes obtained from female donors appear to be more sensitive to the in vitro immunotoxic effects of PFCs when their responses are compared to the results obtained using leukocytes from male donors. Mechanistic investigations demonstrated that inhibition of TNF-α release in THP-1 cells occurred at the transcriptional level. All PFCs, including PFOA and PFOS, decreased LPS-induced NF-κB activation. With the exception of PFOA, none of the PFCs tested was able to activate PPARα driven transcription in transiently transfected THP-1 cells, excluding a role for PPARα in the immunomodulation observed. PFBS and PFDA prevented LPS-induced I-κB degradation. Overall, these studies suggest that PFCs affect NF-κB activation, which directly suppresses cytokine secretion by immune cells. Our results indicate that PFOA is the least active of the PFCs examined followed by PFBS, PFDA, PFOS, PFOSA and fluorotelomer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119708     DOI: 10.1016/j.taap.2011.11.004

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  42 in total

1.  Changing interpretation of human health risks from perfluorinated compounds.

Authors:  Philippe Grandjean; Richard Clapp
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

2.  Serum perfluoroalkyl substances and lung function in adolescents exposed to the World Trade Center disaster.

Authors:  Abigail Gaylord; Kenneth I Berger; Mrudula Naidu; Teresa M Attina; Joseph Gilbert; Tony T Koshy; Xiaoxia Han; Michael Marmor; Yongzhao Shao; Robert Giusti; Roberta M Goldring; Kurunthachalam Kannan; Leonardo Trasande
Journal:  Environ Res       Date:  2019-02-16       Impact factor: 6.498

3.  Environmental perfluorooctane sulfonate exposure drives T cell activation in bottlenose dolphins.

Authors:  Adam C Soloff; Bethany Jacobs Wolf; Natasha D White; Derek Muir; Sean Courtney; Gary Hardiman; Gregory D Bossart; Patricia A Fair
Journal:  J Appl Toxicol       Date:  2017-04-19       Impact factor: 3.446

4.  Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.

Authors:  Philippe Grandjean; Carsten Heilmann; Pal Weihe; Flemming Nielsen; Ulla B Mogensen; Amalie Timmermann; Esben Budtz-Jørgensen
Journal:  J Immunotoxicol       Date:  2017-12       Impact factor: 3.000

Review 5.  Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Authors:  Emanuela Corsini; Robert W Luebke; Dori R Germolec; Jamie C DeWitt
Journal:  Toxicol Lett       Date:  2014-02-03       Impact factor: 4.372

6.  Association between persistent endocrine-disrupting chemicals (PBDEs, OH-PBDEs, PCBs, and PFASs) and biomarkers of inflammation and cellular aging during pregnancy and postpartum.

Authors:  Ami R Zota; Ruth J Geller; Laura E Romano; Kimberly Coleman-Phox; Nancy E Adler; Emily Parry; Miaomiao Wang; June-Soo Park; Angelo F Elmi; Barbara A Laraia; Elissa S Epel
Journal:  Environ Int       Date:  2018-03-10       Impact factor: 9.621

7.  Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates.

Authors:  Katrine Kielsen; Zaiba Shamim; Lars P Ryder; Flemming Nielsen; Philippe Grandjean; Esben Budtz-Jørgensen; Carsten Heilmann
Journal:  J Immunotoxicol       Date:  2015-07-16       Impact factor: 3.000

8.  Perfluorochemicals and endometriosis: the ENDO study.

Authors:  Germaine M Buck Louis; C Matthew Peterson; Zhen Chen; Mary L Hediger; Mary S Croughan; Rajeshwari Sundaram; Joseph B Stanford; Victor Y Fujimoto; Michael W Varner; Linda C Giudice; Anne Kennedy; Liping Sun; Qian Wu; Kurunthachalam Kannan
Journal:  Epidemiology       Date:  2012-11       Impact factor: 4.822

9.  Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults.

Authors:  Cheryl R Stein; Yongchao Ge; Mary S Wolff; Xiaoyun Ye; Antonia M Calafat; Thomas Kraus; Thomas M Moran
Journal:  Environ Res       Date:  2016-05-18       Impact factor: 6.498

10.  In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells.

Authors:  Kristin Midgett; Margie M Peden-Adams; Gary S Gilkeson; Diane L Kamen
Journal:  J Appl Toxicol       Date:  2014-07-23       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.